Department of Health Policy and Management, Emory University, Atlanta, Georgia, USA.
Health Aff (Millwood). 2013 Mar;32(3):596-602. doi: 10.1377/hlthaff.2012.0555.
In 2008 the US Preventive Services Task Force recommended against screening men ages 75 and older for prostate cancer. Using Medicare Current Beneficiary Survey Access to Care files and linked claims, we compared trends in prostate-specific antigen (PSA) testing rates between men ages 75 and older and men ages 65-74. We estimate that the revised recommendation led to a 7.9-percentage-point decline in annual PSA testing rates over two years among men ages 75 and older. Although 42 percent of men in this age group continue to receive PSA tests, our results highlight the potential of guidelines with negative recommendations to reduce the use of low-value medical care.
2008 年，美国预防服务工作组建议不为 75 岁及以上男性筛查前列腺癌。利用医疗保险当前受益人调查获得的医疗服务使用情况文件和相关索赔数据，我们比较了 75 岁及以上男性与 65-74 岁男性的前列腺特异性抗原（PSA）检测率的变化趋势。我们估计，这一修订建议导致 75 岁及以上男性的 PSA 检测率在两年内下降了 7.9 个百分点。尽管这一年龄组中有 42%的男性仍在接受 PSA 检测，但我们的研究结果突出表明，带有负面建议的指南有可能减少低价值医疗保健的使用。
